/ mbeachjeans73's Library/ Notes/ Exactly What Is HIFU and Who Is a Suitable Patient With Prostate Kind Of Cancer?
Exactly What Is HIFU and Who Is a Suitable Patient With Prostate Kind Of Cancer?
from web site
HIFU, or Intense Focused Ultrasound, is a non-surgical method of treatment of localized prostate cancer. HIFU focuses ultrasound energy and soundwaves to a targeted area in the prostate leading to rapid temperature increases and focal ablation in the treatment zone with great accuracy. Generally, HIFU is performed on an outpatient basis in one to 4 hours depending on the height and width of the prostate. The most important advantage of HIFU is definitely a low incontinence rate of under 2% along with a post-treatment erection dysfunction rate of 20 to 30%. The main element to success with HIFU, however, is proper patient selection. Candidates include men with low- to intermediate-risk localized cancer of the prostate (i.e., no spread of cancer not in the prostate). These men would've clinical stage T1 or T2b disease (i.e., no palpable nodule or nodule confined one lobe from the prostate), Gleason score of 7 or less (preferably not more than Gleason Score 3+4=7), PSA a higher level under 20, along with a prostate number of 40 grams or less. Initial data for treatment of appropriately selected men with HIFU has shown results comparable to other modalities pertaining to localized cancer control, biochemical recurrence, and disease-free survival. Additionally, reported incontinence and erection dysfunction rates after HIFU may be low at less that 2% and 20 to 30%, respectively.
Benefits of HIFU as a technique of treating select men with prostate kind of cancer add a non-surgical, noninvasive technique requiring no hospital stay. Additionally, the prostate type of cancer tissue is destroyed without radiation exposure. HIFU is repeatable should re-treatment become necessary later on. Additionally, HIFU enable you to treat recurrent cancer of the prostate which was initially treated by other means, for example radiation or proton therapy. Another impressive putting on HIFU to treat localized prostate cancer is based on emerging successes with focal therapy of prostate type of cancer. Over these select cases, studies would be performed to ensure a low-volume of cancer of the prostate restricted to one lobe or even a specific focal site inside the prostate. The involved lobe or the specific site with the patient's prostate cancer would then be focally treated. Candidates for focal HIFU include men with low-volume (below or corresponding to 3 cores positive for cancer, no core with more than 50% positive), Gleason Score of 6 or fewer, along with a PSA of lower than 10. These men would undergo "template" or "saturation" biopsies with greater to 24 cores evaluated. Recent studies looking at focal therapy of prostate kind of cancer in very select men with low-volume disease are emerging and early results look promising although no long lasting data is yet available. Early brings about some research has shown approximately 90% recurrence free survival following focal therapy in closely monitored men. Incontinence rates following focal HIFU were 0 to 1% and erectile dysfunction rates less than 5% in one study looking at results at three and 6 months following treatment.
HIFU is a minimally invasive treatment alternative for men with low- to intermediate-risk cancer of the prostate. The main element to the success like all options for treatment depends on appropriate candidate selection. HIFU is performed internationally and it is currently undergoing clinical studies for FDA approval in the united states. American urologists are been trained in performing HIFU and work with American teams internationally in order to offer botox cosmetic injections to appropriately selected patients considering HIFU as a means of treating their prostate type of cancer. Remember, make sure to discuss all options using your urologist such as risks, benefits and alternatives to each before making an informed decision regarding treatments for your prostate kind of cancer. Maintain open and honest discussions with your doctor when thinking about these options as the answer to business energy is finding the treatment you like as well as your particular cancer the top.
To get more information about hifu you can check the best website.
Benefits of HIFU as a technique of treating select men with prostate kind of cancer add a non-surgical, noninvasive technique requiring no hospital stay. Additionally, the prostate type of cancer tissue is destroyed without radiation exposure. HIFU is repeatable should re-treatment become necessary later on. Additionally, HIFU enable you to treat recurrent cancer of the prostate which was initially treated by other means, for example radiation or proton therapy. Another impressive putting on HIFU to treat localized prostate cancer is based on emerging successes with focal therapy of prostate type of cancer. Over these select cases, studies would be performed to ensure a low-volume of cancer of the prostate restricted to one lobe or even a specific focal site inside the prostate. The involved lobe or the specific site with the patient's prostate cancer would then be focally treated. Candidates for focal HIFU include men with low-volume (below or corresponding to 3 cores positive for cancer, no core with more than 50% positive), Gleason Score of 6 or fewer, along with a PSA of lower than 10. These men would undergo "template" or "saturation" biopsies with greater to 24 cores evaluated. Recent studies looking at focal therapy of prostate kind of cancer in very select men with low-volume disease are emerging and early results look promising although no long lasting data is yet available. Early brings about some research has shown approximately 90% recurrence free survival following focal therapy in closely monitored men. Incontinence rates following focal HIFU were 0 to 1% and erectile dysfunction rates less than 5% in one study looking at results at three and 6 months following treatment.
HIFU is a minimally invasive treatment alternative for men with low- to intermediate-risk cancer of the prostate. The main element to the success like all options for treatment depends on appropriate candidate selection. HIFU is performed internationally and it is currently undergoing clinical studies for FDA approval in the united states. American urologists are been trained in performing HIFU and work with American teams internationally in order to offer botox cosmetic injections to appropriately selected patients considering HIFU as a means of treating their prostate type of cancer. Remember, make sure to discuss all options using your urologist such as risks, benefits and alternatives to each before making an informed decision regarding treatments for your prostate kind of cancer. Maintain open and honest discussions with your doctor when thinking about these options as the answer to business energy is finding the treatment you like as well as your particular cancer the top.
To get more information about hifu you can check the best website.
